LISTED medicinal cannabis company Bod Australia has advised in an ASX announcement that it dispensed 549 MediCabilis prescriptions in Sep this year, representing a 224% increase on Jul (169) and a 67% increase on Aug (329).
This brings the total prescriptions dispensed for this year to 1,158.
There has been a strong repeat customer trend underpinning the growth, the company said, and the product is now being used to treat 17 different conditions including chronic pain, post traumatic stress disorder, epilepsy, anxiety, dementia, Parkinson's and other neurological conditions.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Oct 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Oct 19